This inventor holds 1 USPTO granted patent. Top assignees: Irbm S.p.a., Istituto Nazionale Di Genetica Molecolare - Ingm, Ospedale San Raffaele S.r.l.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 56 
Years Active: 2025
Title: Luca Ferrante: Innovator in Hepatitis B Research
Introduction
Luca Ferrante is a notable inventor based in Milan, Italy. He has made significant contributions to the field of medical research, particularly in the development of treatments for viral infections.
Latest Patents
Luca Ferrante holds a patent for "Oxalamido-Substituted Tricyclic Inhibitors of Hepatitis B Virus." This innovative work showcases his commitment to advancing medical science and finding effective solutions for combating hepatitis B.
Career Highlights
Throughout his career, Ferrante has worked with esteemed organizations such as Ospedale San Raffaele S.r.l. and Irbm S.p.a. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Luca Ferrante has collaborated with notable colleagues, including Vincenzo Summa and Leda Ivanova Bencheva. These partnerships have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Luca Ferrante's contributions to hepatitis B research through his patent and collaborations highlight his role as an influential inventor in the medical field. His work continues to inspire advancements in treatment options for viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile